Lee Sung — SEC Form 4 filings

SEC reporting owner CIK 1793200. 17 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2024-02-26 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CYTOKINETICS INC (CYTK)EVP, Chief Financial Officer125 legs · 71,817 sh · $5,695,85642
Vir Biotechnology, Inc. (VIR)EVP & Chief Financial Officer21 leg · 6,008 sh · $59,4042
Tango Therapeutics, Inc. (TNGX)Director36

Form 4 filings — Lee Sung

FiledFormIssuerReported transactionsSource
2026-07-024CYTOKINETICS INC (CYTK)Option exercise (M): 1,112 @ $48.51 · Sale (S): 1,112 @ $87.79 · Option exercise (M): 1,112 (derivative) @ $0EDGAR
2026-06-294CYTOKINETICS INC (CYTK)Option exercise (M): 188 @ $44.36 · Option exercise (M): 822 @ $44.36 · Option exercise (M): 1,113 @ $48.51 · Option exercise (M): 188 @ $44.36 · Option exercise (M): 823 @ $44.36 · Sale (S): 3,134 @ $85 · +5 moreEDGAR
2026-06-294CYTOKINETICS INC (CYTK)Option exercise (M): 23,370 @ $48.51 · Option exercise (M): 9,307 @ $44.36 · Option exercise (M): 2,817 @ $44.36 · Option exercise (M): 1,113 @ $48.51 · Option exercise (M): 188 @ $44.36 · Option exercise (M): 822 @ $44.36 · +9 moreEDGAR
2026-06-084Tango Therapeutics, Inc. (TNGX)Grant/award (A): 570 @ $0 · Grant/award (A): 3,570 (derivative) @ $0EDGAR
2026-05-054CYTOKINETICS INC (CYTK)Sale (S): 23,906 @ $76.87EDGAR
2026-05-014Tango Therapeutics, Inc. (TNGX)Grant/award (A): 12,300 @ $0 · Grant/award (A): 5,200 (derivative) @ $0EDGAR
2026-03-184CYTOKINETICS INC (CYTK)Sale (S): 4,935 @ $62.15EDGAR
2026-03-174CYTOKINETICS INC (CYTK)Grant/award (A): 20,646 @ $0 · Grant/award (A): 1,665 (derivative) @ $0 · Grant/award (A): 29,480 (derivative) @ $0EDGAR
2026-01-064Tango Therapeutics, Inc. (TNGX)Grant/award (A): 10,000 @ $0 · Grant/award (A): 60,000 (derivative) @ $0EDGAR
2025-12-294CYTOKINETICS INC (CYTK)Grant/award (A): 2,152 @ $0 · Grant/award (A): 2,152 @ $0 · Tax withholding (F): 805 @ $62.72EDGAR
2025-12-054CYTOKINETICS INC (CYTK)Tax withholding (F): 1,560 @ $65.02EDGAR
2025-06-034CYTOKINETICS INC (CYTK)Tax withholding (F): 4,965 @ $31.21EDGAR
2025-03-184CYTOKINETICS INC (CYTK)Grant/award (A): 32,687 @ $0 · Grant/award (A): 9,016 (derivative) @ $0 · Grant/award (A): 41,326 (derivative) @ $0EDGAR
2024-12-054CYTOKINETICS INC (CYTK)Grant/award (A): 4,303 @ $0 · Tax withholding (F): 1,536 @ $51.51 · Grant/award (A): 4,304 @ $0EDGAR
2024-06-034CYTOKINETICS INC (CYTK)Grant/award (A): 34,684 @ $0 · Grant/award (A): 53,417 (derivative) @ $0EDGAR
2024-03-284Vir Biotechnology, Inc. (VIR)Sale (S): 6,008 @ $9.89EDGAR
2024-02-264Vir Biotechnology, Inc. (VIR)Grant/award (A): 40,000 @ $0 · Grant/award (A): 80,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1793200 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →